T1	Participants 64 91	heart transplant recipients
T2	Participants 476 503	heart-transplant recipients
T3	Participants 513 604	Twenty heart-transplant recipients were randomised into either a treated or a placebo group
T4	Participants 1227 1355	one patient in the ticlopidine group was withdrawn because of a major fall in cyclosporin blood level within 3 days of treatment
